Driven by their Covid-19 vaccine sales, Pfizer, Moderna, AstraZeneca, and Johnson & Johnson made a combined $231 billion in revenues in 2021. These four healthcare heavyweights are also expecting big gains in 2022, capitalizing on booster requirements.
